"","Num","POD","SD","%","Genes","KE"
"GO:0005102","1","0.001904414",NA,"0.48","30664","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0099536","1","0.001904414",NA,"0.9","30664","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:1903008","1","0.001904414",NA,"7.69","30664","DISRUPTION LYSOSOME"
"ADRENERGIC RECEPTOR SIGNALING PATHWAY","1","0.001904414",NA,"12.5","30664","INCREASED ACTIVITY BETA-2 ADRENERGIC RECEPTOR; ACTIVATION BETA-2 ADRENERGIC RECEPTOR"
"PYRUVATE METABOLIC PROCESS","2","0.0061293544401511","1.59248975950964","3.57","798071, 406428","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"GO:0019882","4","0.00998036343915567","0.760702117703249","6.78","393544, 798071, 326884, 415221","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"GO:0003824","2","0.0137386987154126","1.34462700867484","3.08","436949, 406428","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0006839","3","0.0199798649039844","0.38392349546447","6.52","30664, 449787, 564379","REDUCTION CHOLESTEROL TRANSPORT IN MITOCHONDRIA"
"GO:0019932","2","0.0286649008209944","0.8326812225164","3.28","30664, 449548","INCREASED SECOND MESSENGER PRODUCTION"
"REGULATION OF WNT SIGNALING PATHWAY","5","0.0473367501529475","0.475537425257877","6.33","393544, 30664, 449548, 326884, 415221","INHIBITION WNT PATHWAY"
"GO:1903009","3","0.0661348595297105","1.04567786924414","8.82","393544, 326884, 415221","DECREASE GTPCH-1"
"CTOME CELLULAR RESPONSE TO HYPOXIA","3","0.0661348595297105","1.04567786924414","6.98","393544, 326884, 415221","N/A HYPOXIA"
"G OOCYTE MEIOSIS","3","0.0963293893358397","0.436680428506719","7.5","100003223, 449548, 399480","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"GO:0030163","6","0.128313537322416","0.387032213754003","3.92","393544, 30664, 100329779, 326884, 30646, 415221","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"GO:0046903","5","0.129756849603675","0.441464474558322","2.16","393544, 323462, 399480, 100329779, 100002928","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"HEART DEVELOPMENT","3","0.13529348507655","0.539332874989027","2.38","30664, 399480, 100329779","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"UPPER MOTOR NEURON DYSFUNCTION","5","0.156657142592528","0.341202346730446","1.05","436949, 556538, 30430, 321928, 30646","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"ABNORMAL NASAL MORPHOLOGY","3","0.169130824153256","0.529560379012275","1.94","100003223, 449548, 436760","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0007568","3","0.171285186042702","0.577391358565354","3.49","30664, 399480, 406349","ACCELERATED AGING"
"GO:0001775","6","0.217631438201273","0.341583943821913","3.06","393544, 323462, 399480, 100329779, 436946, 100002928","ACTIVATION DENDRITIC CELLS"
"REGULATION OF PROTEOLYSIS","4","0.242266683979981","0.371949671674536","3.57","30664, 415158, 100329779, 326884","IMPAIRED PROTEOSTASIS"
"APOPTOSIS","1","0.255772071",NA,"1.79","415158","INCREASED APOPTOSIS ADENOMAS/CARCINOMAS FOLLICULAR CELL"
"DNA DAMAGE RESPONSE","1","0.255772071",NA,"1.72","415158","INCREASED DNA DAMAGE-REPAIR"
"FAS LIGAND FASL PATHWAY AND STRESS INDUCTION OF HEAT SHOCK PROTEINS HSP REGULATION","1","0.255772071",NA,"3.85","415158","ACTIVATION FAS; UP REGULATION FAS"
"OXIDATIVE DAMAGE","1","0.255772071",NA,"5","415158","INCREASED OXIDATIVE DAMAGE"
"CTOME REGULATED NECROSIS","1","0.255772071",NA,"4.76","415158","INCREASE NECROSIS TERMINAL BRONCHIOLAR CELLS"
"REGULATION OF CELL DEATH","6","0.258783134295723","0.185174262762727","2.24","30664, 791146, 30430, 449548, 323462, 406349","N/A CELL INJURY/DEATH"
"POSITIVE REGULATION OF GENE EXPRESSION","5","0.33221081047937","0.261286280565206","2.76","30664, 30430, 399480, 100329779, 406349","ALTERED GENE EXPRESSION"
"NEGATIVE REGULATION OF FAT CELL PROLIFERATION","1","0.369187989",NA,"25","791146","INDUCTION SUSTAINED CELL PROLIFERATION"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","4","0.382089398320084","0.360367546829904","2.72","100003223, 321928, 321793, 393703","INCREASED RESPIRATORY DISTRESS/ARREST"
"ABNORMAL LUNG MORPHOLOGY","4","0.382089398320084","0.360367546829904","3.12","100003223, 321928, 321793, 393703","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"GO:0008137","1","0.394379883",NA,"11.11","556538","INHIBITION NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"GO:0008213","1","0.428998293",NA,"14.29","30430","ALKYLATION PROTEIN"
"GO:0006305","1","0.428998293",NA,"33.33","30430","ALKYLATION DNA; FORMATION PRO-MUTAGENIC DNA ADDUCTS"
"ABNORMALITY OF THE BLADDER","1","0.428998293",NA,"1.92","30430","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"GO:0007051","1","0.431458989",NA,"3.7","449548","DISORGANIZATION SPINDLE"
"GO:0007059","1","0.431458989",NA,"2.27","449548","INCREASED CHROMOSOME MISSEGGREGATION"
"GO:0048469","1","0.431458989",NA,"4.17","449548","INCREASED OOCYTE MATURATION"
"HYPERACTIVITY","1","0.431458989",NA,"2","449548","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"TUBE FEEDING","1","0.431458989",NA,"5.88","449548","INHIBITION FEEDING"
"GO:0046983","3","0.481831679442703","0.0485571344157977","1.52","791146, 449548, 337230","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"GO:0040011","5","0.488676915386458","0.275227475257732","2.2","30664, 399480, 100329779, 100002928, 406349","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0048870","5","0.488676915386458","0.275227475257732","2.5","30664, 399480, 100329779, 100002928, 406349","INCREASED MOTILITY"
"GO:0005488","21","0.511193924710286","0.0478162498911345","1.95","30664, 100003223, 406326, 415196, 564379, 791146, 30430, 323462, 399480, 337230, 321928, 619259, 100329779, 321793, 394028, 100002928, 446119, 406467, 569063, 326884, 406349","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"GO:0006412","3","0.518493726689742","0.310717185725019","2.78","415196, 337230, 436760","ALTERED PROTEIN PRODUCTION"
"PEPTIDYL LYSINE MODIFICATION","2","0.545174471530684","0.073595636413709","2.82","30430, 399480","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"GO:0006629","2","0.546735771968358","0.0727174248600768","0.97","449548, 399480","ALTERATION LIPID METABOLISM"
"DECREASED BODY WEIGHT","8","0.590811990496754","0.126267160790269","3.54","100003223, 556538, 573021, 321928, 406428, 321793, 436760, 393703","DECREASED BODY WEIGHT"
"ELECTRON TRANSPORT CHAIN","6","0.614701606173723","0.0763328273021905","8.82","415158, 564379, 556538, 573021, 321928, 393703","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0016310","6","0.616780670752889","0.209203085838727","4.8","30664, 399480, 100329779, 321793, 394028, 406349","ACTIVATION SP1"
"GO:0045333","6","0.654793200744184","0.0781660879678376","8.33","415158, 564379, 556538, 573021, 406428, 393703","INCREASE OXIDATIVE METABOLISM"
"GO:0010468","1","0.692812091",NA,"6.25","399480","DECREASED TRANSCRIPTION OF GENES BY AR"
"GO:0042060","1","0.692812091",NA,"1.14","399480","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"GO:0042701","1","0.692812091",NA,"2.94","399480","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"GO:0050663","1","0.692812091",NA,"3.33","399480","RELEASE CYTOKINE"
"DISRUPTION OF POSTSYNAPTIC SIGNALLING BY CNV","1","0.692812091",NA,"10","399480","REDUCTION EXCITATORY POSTSYNAPTIC POTENTIAL; GENERATION AMPLIFIED EXCITATORY POSTSYNAPTIC POTENTIAL EPSP"
"ENDOMETRIAL CANCER","1","0.692812091",NA,"1.47","399480","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","1","0.692812091",NA,"2.94","399480","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"CTOME RHO GTPASES ACTIVATE NADPH OXIDASES","1","0.692812091",NA,"16.67","399480","ACTIVATION NADPH OXIDASE"
"REGULATION OF PH","1","0.692812091",NA,"7.14","399480","DECREASE INTRACELLULAR PH"
"RESPONSE TO REACTIVE OXYGEN SPECIES","1","0.692812091",NA,"1.79","399480","INCREASED REACTIVE OXYGEN SPECIES"
"G VEGF SIGNALING PATHWAY","1","0.692812091",NA,"4.76","399480","REDUCED PRODUCTION VEGF"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","1","0.74971547",NA,"0.97","321928","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"GO:0072358","2","0.897335183422032","0.226627109692983","1.8","30430, 100329779","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"GO:0006120","3","0.926108175078445","0.203303979420028","11.11","556538, 573021, 393703","BINDING OF INHIBITOR NADH-UBIQUINONE OXIDOREDUCTASE COMPLEX I"
"ABNORMALITY OF THE MITOCHONDRION","6","0.954781775090735","0.0736384951054681","4.76","556538, 30430, 573021, 406428, 321793, 393703","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"BREAST CANCER PATHWAY","3","0.991323046906415","0.174792502873644","2.63","791146, 399480, 406349","N/A BREAST CANCER"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","6","1.08761159288815","0.0801397118483789","1.49","415158, 556538, 321928, 321793, 394028, 436760","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"GO:0009790","5","1.09523057141072","0.0758297730417603","2.96","30430, 399480, 321928, 100329779, 326884","DEFECT OF EMBRYOGENESIS"
"GO:0004738","1","1.09530571",NA,"25","406428","INCREASED INDUCTION OF PYRUVATE DEHYDROGENASE PDH; INHIBITION PYRUVATE DEHYDROGENASE KINASE PDK ENZYME"
"G TGF BETA SIGNALING PATHWAY","4","1.20905998745013","0.106415792597362","5.88","449548, 399480, 100329779, 406349","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"SMOOTH MUSCLE CELL PROLIFERATION","2","1.27825963724079","0.335284234438316","7.69","30430, 406349","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"GO:0000003","4","1.38989624623472","0.119027327269448","1.97","449548, 399480, 336637, 406349","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0044703","4","1.38989624623472","0.119027327269448","3.45","449548, 399480, 336637, 406349","N/A REPRODUCTIVE FAILURE"
"ABNORMAL SOCIAL BEHAVIOR","2","1.41917254211008","0.366676007471196","7.69","573021, 393703","ABNORMAL FORAGING ACTIVITY AND BEHAVIOR"
"RENAL TUBULAR DYSFUNCTION","2","1.41917254211008","0.366676007471196","7.69","573021, 393703","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"GO:0001816","2","1.4307233632885","0.222696358655483","1.67","399480, 100002928","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0009611","2","1.62442259930333","0.261688598024607","1.79","399480, 406349","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"HUMAN THYROID STIMULATING HORMONE TSH SIGNALING PATHWAY","2","1.62442259930333","0.261688598024607","1.85","399480, 406349","DECREASED TRIIODOTHYRONINE T3 IN SERUM; INCREASE THYROID-STIMULATING HORMONE TSH; DECREASED THYROXINE T4 IN SERUM; INCREASED THYROID-STIMULATING HORMONE TSH"
"GO:0046562","2","1.78826069292987","0.150539836795629","7.41","406428, 100005587","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"ABNORMAL LIVER MORPHOLOGY","3","1.79582637337989","0.182651758332996","2.52","573021, 394028, 393703","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"ABNORMALITY OF THE ABDOMINAL ORGANS","3","1.79582637337989","0.182651758332996","1.78","573021, 394028, 393703","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"ABNORMALITY OF THE LIVER","3","1.79582637337989","0.182651758332996","0.4","573021, 394028, 393703","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"MORTALITY AGING","2","1.87389359826137","0.281321340519658","7.69","321928, 393703","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"GO:0003158","1","1.876954861",NA,"4.17","100329779","IMPAIRMENT ENDOTHELIAL NETWORK"
"GO:0007249","1","1.876954861",NA,"2.33","100329779","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"GO:0006936","2","2.67373405619692","0.108657124745333","3.64","100329779, 406349","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"GO:0006954","1","3.122708943",NA,"0.85","406467","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"GO:0019904","3","3.25998705893875","0.01973099337466","2.44","100002928, 446119, 406349","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0016209","1","3.277871776",NA,"9.09","336637","OXIDATION GLUTATHIONE"
"ELEVATED RED CELL ADENOSINE DEAMINASE LEVEL","1","3.749793331",NA,"5.56","436760","INCREASED CYCLIC ADENOSINE MONOPHOSPHATE"
"PURE RED CELL APLASIA","1","3.749793331",NA,"5","436760","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER"
"CYTOPLASMIC RIBOSOMAL PROTEINS","2","3.77915722059544","0.00239541436078399","1.39","436760, 406349","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"GO:0015908","1","3.808751053",NA,"4.55","406349","INCREASED FA INFLUX"
